Idiopathic Pulmonary Fibrosis

Latest News in Idiopathic Pulmonary Fibrosis

June 30, 2024

The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis – Frontiers

June 27, 2024

Integrating Patient Perspectives into Personalized Medicine in Idiopathic Pulmonary Fibrosis – Frontiers

June 27, 2024

Multiomic analysis of monocyte-derived alveolar macrophages in idiopathic pulmonary fibrosis – Journal of Translational Medicine

June 27, 2024

Mesenchymal Stem Cells for the Treatment of Idiopathic Pulmonary Fibrosis – Frontiers

June 26, 2024

Clinical implications of interstitial pneumonia with autoimmune features diagnostic criteria in idiopathic pulmonary fibrosis: A case control study – Frontiers

122 Active Idiopathic Pulmonary Fibrosis Clinical Trials

As of November 12, 2024

Source: clinicaltrials.gov

LOCATE

CLINICAL TRIALS

BROWSE

FDA-approved DRUGS

FIND

A DOCTOR EXPERT™

WHAT IS

CONGRESS DOING?